These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 11334325

  • 1. Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution.
    Souid M, Terki NH, Nochy D, Hillion D.
    Clin Nephrol; 2001 Apr; 55(4):337-8. PubMed ID: 11334325
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
    Okano K, Yumura W, Nitta K, Honda K, Uchida K, Nihei H.
    Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D.
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report].
    Mizutani A, Tanaka I, Katayama M, Oshima H, Komatsu Y, Asano S, Kato K, Matsumura H, Ishii K, Miyama H, Nagai T, Kato K, Fukaya S, Yoshida S, Hasegawa M, Kawashima S, Torikai K.
    Ryumachi; 2000 Oct; 40(5):828-32. PubMed ID: 11215162
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW.
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [Abstract] [Full Text] [Related]

  • 17. Coexistence of anti-GBM antibodies and MPO-ANCA in a patient with systemic vasculitis and crescentic glomerulonephritis.
    Fernandes P, Lopes JA, Correia L, Gonçalves S, Jorge S.
    Nefrologia; 2010 Aug; 30(6):709-10. PubMed ID: 21113229
    [No Abstract] [Full Text] [Related]

  • 18. Significance of myeloperoxidase in rapidly progressive glomerulonephritis.
    Saeki T, Kuroda T, Morita T, Suzuki K, Arakawa M, Kawasaki K.
    Am J Kidney Dis; 1995 Jul; 26(1):13-21. PubMed ID: 7611243
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Membranous glomerulopathy induced by myeloperoxidase-anti-neutrophil cytoplasmic antibody-related crescentic glomerulonephritis.
    Suwabe T, Ubara Y, Tagami T, Sawa N, Hoshino J, Katori H, Takemoto F, Hara S, Aita K, Hara S, Takaichi K.
    Intern Med; 2005 Aug; 44(8):853-8. PubMed ID: 16157986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.